It is the largest & most informative healthcare investment symposium in the industry!

2019 J.P. Morgan Health Care Investor Conference - January 7–10, 2019 | San Francisco

We will be there to introduce our expertise in macrocyclization of small Lead-like molecules & our R&D kinase inhibitor programs available under adhoc agreements.

 Fabrice Viviani - Experimentation Strategic Activity Director will be available to fix meetings

This email address is being protected from spambots. You need JavaScript enabled to view it.

%MCEPASTEBIN%

 

 

 

2-day conference on Immunotherapies for prevention and treatment of infectious diseases!

Web I4ID event immunotherapies

 Come and meet Emilie Soulier - Business Account Manager - to discuss your project and find out how Oncodesign's immuno services can support your program!

This email address is being protected from spambots. You need JavaScript enabled to view it.

%MCEPASTEBIN%

 

Increase your overall understanding of the potential of Immunotherapy and its implications for clinical practice!

ESMO Immuno-Oncology Congress – 13-16 Decembre – Genève, Suisse

 Come at the poster session & meet Marc Hillairet - Study Director - to discover the latest data presented in partnership with IPSEN: 

"Cabozantinib in combination with anti-PD immune checkpoint inhibitor in syngeneic tumor mouse models"

Marc Hillairet de Boisferon, PhD, Directeur d’études, Oncodesign
Sophie Rolland, Research Manager, Oncology Therapeutic Area, R&D, Translational Sciences, IPSEN

This email address is being protected from spambots. You need JavaScript enabled to view it.

%MCEPASTEBIN

 

Join the leaders of the immuno-oncology community in Berlin! 

ICI Europe Summit – 27-29 Novembre – Berlin, Allemagne

Come & plan on meeting with Keith Payne, Business Account Manager, to discuss your project and investigate how Oncodesign can support your Immuno-Oncology (IO) pipeline!

This email address is being protected from spambots. You need JavaScript enabled to view it.

%MCEPASTEBIN

By closing this message, you consent to our cookies on this device in accordance with our cookie policy unless you have disabled them.